dual glp-1/gip receptor agonists The Sustained Effects of a GIP/GLP-1 Agonist, NNC0090-2746, in Patients with Type 2 Diabetes: Cell Metabolism Frontiers | GLP-1/GIP dual agonist

Both are injectable semaglutide formulations

However, patients should expect gastrointestinal side effects during the first weeks on Ozempic even if they tolerated Januvia well

Some providers may prescribe phentermine for a few weeks to kickstart weight loss while a patient is slowly titrating up to their full dose of a GLP-1

Vassiliadis, E

Meanwhile, a study published on April 17, 2026, suggested that taking a drug like semaglutide (the main ingredient in Ozempic) may be associated with an increased risk of some patients experiencing hair loss

If a person needs a higher dose to manage their blood sugar, there is also a 9 mg dose